Interaction Checker

Meet the Team

The Cancer Drug Interactions website was set up in 2017 and is a joint venture between Radboud University Medical Centre in Nijmegen, Netherlands and the University of Liverpool, UK.

2017 vanerp

Dr Nielka van Erp

(Clinical Leadership)

Nielka is a Hospital Pharmacist specialising in oncolytic patient care at Radboud University Medical Centre. Her main research interest is the pharmacology of oncolytics and her research involves pharmacokinetic/pharmacodynamic behaviour of targeted oncolytic drugs used for solid tumours. She is interested in identifying those patients who will benefit most from an individualized dose.
2017 lankheet

Dr Nienke Lankheet

(Content Development)

Nienke is a Hospital Pharmacist, specialist in oncology patient care and Clinical Pharmacologist in training at Radboud University Medical Centre in Nijmegen. She obtained her PhD from the Netherlands Cancer Institute in Amsterdam for a research project into the clinical pharmacology of targeted agents in oncology. She is particularly interested in the pharmacology of oncolytics and therapeutic drug monitoring.

2018 ferrier

Kaylee Ferrier

(Content Development)

Kaylee graduated from the University of Utrecht as a pharmacist and was first involved in this website during her internship at the hospital pharmacy of the Radboudumc.  Since September 2017, Kaylee has been working full time on this project researching the drug interactions and preparing the summaries for the website.

2018 krens resized

Stefanie Krens

(Content Developer)

Stefanie joined the team after finishing her training as a Hospital Pharmacist in May 2018. She is a PhD candidate and a Hospital Pharmacist Fellow specialising in oncology patient care at the Radboud University Medical Center. She is particularly interested in strategies to enhance efficacy and reduce toxicity of anti-cancer agents.

2018 martin updated

Jasmine Martin

(Content Manager)

Jasmine obtained a BSc (Hons) degree in Pharmacology from the University of Liverpool in 2016 and, after completing a Master degree by research, she joined the website team in August 2017. Jasmine is responsible for the final review of the interaction summaries and for the management of the interaction database and its content.

2018 jansman updated

Dr Frank Jansman

(Scientific/Clinical Leadership)

Frank is a Hospital Pharmacist and Clinical Pharmacologist at the Deventer Teaching Hospital and at the University Groningen. He is particularly interested in pharmacotherapy and pharmaceutical care of cancer patients and in clinical toxicology. Frank is chairman of the Dutch Working Group for Interactions Anticancer Drugs (Dutch Association of Hospital Pharmacists, Dutch Society for Medical Oncology, Haemato Oncology Foundation for Adults in the Netherlands, Dutch Society of Clinical Pharmacology and Biopharmacy) and chairman of the Dutch Working Group for Pharmacotherapy and Drug Information (Royal Dutch Pharmacists Association).

2016 burger

Prof David Burger

(Scientific Leadership)

David is a Professor of Clinical Pharmacy, Radboud University Nijmegen and is (co-) author of more than 350 publications in this field. The topics of his interest are drug-drug interactions, paediatric pharmacology, therapeutic drug monitoring, and operational research in resource-limited countries. David is member of the Editorial Board of www.hiv-druginteractions.org and www.hep-druginteractions.org and member of the Organizing Committee of the annual International Workshop on Clinical Pharmacology of Antiviral Therapy.

2016 khoo

Prof Saye Khoo

(Scientific Leadership)

Saye is a Professor of Clinical Pharmacology at the University of Liverpool and Honorary Consultant Physician, Royal Liverpool and Broadgreen University Hospitals NHS Trust. His primary research interests centre on the pharmacology of HIV treatment failure, including investigation of drug interactions, the role of therapeutic drug monitoring, population pharmacokinetic modelling, molecular characterisation of drug metabolism and disposition pathways and the role of host genetic variability in influencing drug exposure and response. 

Along with Em Prof David Back, Saye founded and leads the sister sites www.hiv-druginteractions.org and www.hep-druginteractions.org.

2017 mcallister

Katie McAllister

(Business Development Manager)

Katie is responsible for fundraising for the team and for developing partnerships and projects which support our mission and ethos. Please contact her at katiemc@liverpool.ac.uk if you are interested in supporting us or working with us.

ENDORSED BY
Bopa